The data support the hypothesis that the STAT3 upregulation expression level difference between the two groups, tumour vs normal, is a molecular feature involved in the GC samples’ response to platinum-based chemotherapy drugs (Figure 1). The gene discussed is STAT3; the disease is gastric cancer.